Erk1/2 MAP kinases are required for epidermal G2/M progression

Journal of Cell Biology

Volumn 185, Issue 3, 2009, Pages 409-422

  Dumesic, Phillip A ^a,b   Scholl, Florence A ^a,b   Barragan, Deborah I ^a,b   Khavari, Paul A ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; S6 KINASE; CYCLIN B; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIVISION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; ENZYME ACTIVITY; EPIDERMIS CELL; EPITHELIUM CELL; FIBROBLAST; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CELL CYCLE; CYTOLOGY; ENZYME ACTIVATION; ENZYMOLOGY; EPIDERMIS; GENE EXPRESSION REGULATION; GENETICS; KERATINOCYTE; METABOLISM; MOUSE; MOUSE MUTANT; NEOPLASM; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION; XENOGRAFT;

ANIMALS; CDC2 PROTEIN KINASE; CELL CYCLE; CELL DIVISION; CYCLIN B; ENZYME ACTIVATION; EPIDERMIS; EPITHELIAL CELLS; FIBROBLASTS; G2 PHASE; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MICE; MICE, SCID; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASMS; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS;

EID: 65649099808     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200804038     Document Type: Article

References (50)

1. Bamberger, A.M., K. Milde-Langosch, E. Rossing, C. Goemann, and T. Loning. 2001. Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J. Cancer Res. Clin. Oncol. 127:545-550.
2. Bourcier, C., A. Jacquel, J. Hess, I. Peyrottes, P. Angel, P. Hofman, P. Auberger, J. Pouyssegur, and G. Pages. 2006. p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis. Cancer Res. 66:2700-2707.
3. Brahma, A., and K.N. Dalby. 2007. Regulation of protein phosphorylation within the MKK1-ERK2 complex by MP1 and the MP1*P14 heterodimer. Arch. Biochem. Biophys. 460:85-91.
4. Chambard, J.C., R. Lefloch, J. Pouyssegur, and P. Lenormand. 2007. ERK implication in cell cycle regulation. Biochim. Biophys. Acta. 1773:1299-1310.
5. Cheng, M., V. Sexl, C.J. Sherr, and M.F. Roussel. 1998. Assembly of cyclin D- dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA. 95:1091-1096.
6. Cheng, M., P. Olivier, J.A. Diehl, M. Fero, M.F. Roussel, J.M. Roberts, and C.J. Sherr. 1999. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571-1583.
7. Choate, K.A., D.A. Medalie, J.R. Morgan, and P.A. Khavari. 1996. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat. Med. 2:1263-1267.
8. Dajee, M., M. Tarutani, H. Deng, T. Cai, and P.A. Khavari. 2002. Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation. Oncogene. 21:1527-1538.
9. Dajee, M., M. Lazarov, J.Y. Zhang, T. Cai, C.L. Green, A.J. Russell, M.P. Marinkovich, S. Tao, Q. Lin, Y. Kubo, and P.A. Khavari. 2003. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature. 421:639-643.
10. Emrick, M.A., A.N. Hoofnagle, A.S. Miller, L.F. Ten Eyck, and N.G. Ahn. 2001. Constitutive activation of extracellular signal-regulated kinase 2 by syn- ergistic point mutations. J. Biol. Chem. 276:46469-46479.
11. Fischer, A.M., C.D. Katayama, G. Pages, J. Pouyssegur, and S.M. Hedrick. 2005. The role of erk1 and erk2 in multiple stages of T cell development. Immunity. 23:431-443.
12. Fremin, C., F. Ezan, P. Boisselier, A. Bessard, G. Pages, J. Pouyssegur, and G. Baffet. 2007. ERK2 but not ERK1 plays a key role in hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes. Hepatology. 45:1035-1045.
13. Frodin, M., and S. Gammeltoft. 1999. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol. 151:65-77.
14. Gazel, A., R.I. Nijhawan, R. Walsh, and M. Blumenberg. 2008. Transcriptional profiling defines the roles of ERK and p38 kinases in epidermal keratino- cytes. J. Cell. Physiol. 215:292-308.
15. Hatano, N., Y. Mori, M. Oh-hora, A. Kosugi, T. Fujikawa, N. Nakai, H. Niwa, J. Miyazaki, T. Hamaoka, and M. Ogata. 2003. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells. 8:847-856.
16. Hoshino, R., Y. Chatani, T. Yamori, T. Tsuruo, H. Oka, O. Yoshida, Y. Shimada, S. Ari-i, H. Wada, J. Fujimoto, and M. Kohno. 1999. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene. 18:813-822.
17. Hyun, J., I. Becam, C. Yanicostas, and D. Bohmann. 2006. Control of G2/M transition by Drosophila Fos. Mol. Cell. Biol. 26:8293-8302.
18. Kim, D.S., H.K. Lee, S.H. Park, S. Lee, I.J. Ryoo, W.G. Kim, I.D. Yoo, J.I. Na, S.B. Kwon, and K.C. Park. 2008. Terrein inhibits keratinocyte proliferation via ERK inactivation and G2/M cell cycle arrest. Exp. Dermatol.
19. 17:312-317.
20. Kinsella, T.M., and G.P. Nolan. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1405-1413.
21. Kohno, M., and J. Pouyssegur. 2006. Targeting the ERK signaling pathway in cancer therapy. Ann. Med. 38:200-211.
22. Lavoie, J.N., G. L'Allemain, A. Brunet, R. Mliller, and J. Pouyssegur. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608-20616.
23. Lazarov, M., Y. Kubo, T. Cai, M. Dajee, M. Tarutani, Q. Lin, M. Fang, S. Tao, C.L. Green, and P.A. Khavari. 2002. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nat. Med. 8:1105-1114.
24. Lazarov, M., C.L. Green, J.Y. Zhang, Y. Kubo, M. Dajee, and P.A. Khavari. 2003. Escaping G1 restraints on neoplasia: Cdk4 regulation by Ras and NF- KappaB. Cell Cycle. 2:79-80.
25. Liu, F., C. Rothblum-Oviatt, C.E. Ryan, and H. Piwnica-Worms. 1999. Overproduction of human Myt1 kinase induces a G2 cell cycle delay by
26. interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes. Mol. Cell. Biol. 19:5113-5123.
27. Liu, X., S.Yan, T. Zhou, Y. Terada, and R.L. Erikson. 2004. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene. 23:763-776.
28. Meloche, S., and J. Pouyssegur. 2007. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene. 26:3227-3239.
29. Murphy, L.O., S. Smith, R.H. Chen, D.C. Fingar, and J. Blenis. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4:556-564.
30. Niida, H., S. Tsuge, Y. Katsuno, A. Konishi, N. Takeda, and M. Nakanishi. 2005. Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J. Biol. Chem. 280:39246-39252.
31. Pages, G., S. Guerin, D. Grall, F. Bonino, A. Smith, F. Anjuere, P. Auberger, and J. Pouyssegur. 1999. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science. 286:1374-1377.
32. Pelech, S. 2006. Dimerization in protein kinase signaling. J. Biol. 5:12.
33. Pouyssegur, J., and P. Lenormand. 2003. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur. J. Biochem. 270:3291-3299.
34. Roberts, E.C., P.S. Shapiro, T.S. Nahreini, G. Pages, J. Pouyssegur, and N.G. Ahn. 2002. Distinct cell cycle timing requirements for extracellular signal- regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis. Mol. Cell. Biol. 22:7226-7241.
35. Saba-El-Leil, M.K., F.D. Vella, B. Vernay, L. Voisin, L. Chen, N. Labrecque, S.L. Ang, and S. Meloche. 2003. An essential function of the mitogen- activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep. 4:964-968.
36. Scholl, F.A., P.A. Dumesic, and P.A. Khavari. 2004. Mek1 alters epidermal growth and differentiation. Cancer Res. 64:6035-6040.
37. Scholl, F.A., P.A. Dumesic, D.I. Barragan, K. Harada, V. Bissonauth, J. Charron, and P.A. Khavari. 2007. Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia. Dev. Cell. 12:615-629.
38. Shaul, Y.D., and R. Seger. 2007. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta. 1773:1213-1226.
39. Shinohara, M., A.V. Mikhailov, J.A. Aguirre-Ghiso, and C.L. Rieder. 2006. Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis. Mol. Biol. Cell. 17:5227-5240.
40. Silverman, E., M. Frodin, S. Gammeltoft, and J.L. Maller. 2004. Activation of p90 Rsk1 is sufficient for differentiation of PC12 cells. Mol. Cell. Biol. 24:10573-10583.
41. Tarutani, M., T. Cai, M. Dajee, and P.A. Khavari. 2003. Inducible activation of Ras and Raf in adult epidermis. Cancer Res. 63:319-323.
42. Truong, A.B., M. Kretz, T.W. Ridky, R. Kimmel, and P.A. Khavari. 2006. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev. 20:3185-3197.
43. Vantaggiato, C., I. Formentini, A. Bondanza, C. Bonini, L. Naldini, and R. Brambilla. 2006. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J. Biol. 5:14.
44. Villanueva, J., Y. Yung, J.L. Walker, and R.K. Assoian. 2007. ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. Mol. Biol. Cell. 18:1457-1463.
45. Wang, R., G. He, M. Nelman-Gonzalez, C.L. Ashorn, G.E. Gallick, P.T. Stukenberg, M.W. Kirschner, and J. Kuang. 2007. Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell. 128:1119-1132.
46. Wright, J.H., E. Munar, D.R. Jameson, P.R. Andreassen, R.L. Margolis, R. Seger, and E.G. Krebs. 1999. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibro- blasts. Proc. Natl. Acad. Sci. USA. 96:11335-11340.
47. Yamamoto, T., M. Ebisuya, F. Ashida, K. Okamoto, S.Yonehara, and E. Nishida. 2006. Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression. Curr. Biol. 16:1171-1182.
48. Yao, Y, W. Li, J. Wu, U.A. Germann, M.S. Su, K. Kuida, and D.M. Boucher. 2003. Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc. Natl. Acad. Sci. USA. 100:12759-12764.
49. Yoon, S., and R. Seger. 2006. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors. 24:21-44.
50. Zeng, P., H.A. Wagoner, O.H. Pescovitz, and R. Steinmetz. 2005. RNA interference (RNAi) for extracellular signal-regulated kinase 1 (ERK1) alone is sufficient to suppress cell viability in ovarian cancer cells. Cancer Biol. Ther. 4:961-967.